H3N2 RG-A/Texas/71/2017 influenza vaccine (NIAID)

N/A

Report date: 2022/12/31 17:30:03

Base Information

Drug NameH3N2 RG-A/Texas/71/2017 influenza vaccine (NIAID)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A